Barish Edil to Capecitabine
This is a "connection" page, showing publications Barish Edil has written about Capecitabine.
Connection Strength
0.061
-
Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer. Am J Clin Oncol. 2016 Feb; 39(1):18-26.
Score: 0.033
-
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):678-85.
Score: 0.028